Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment | Zendy

Marina Boccardi | Zendy; Daniele Altomare | Zendy; Clarissa Ferrari | Zendy; Cristina Festari | Zendy; Ugo Paolo Guerra | Zendy; Barbara Paghera | Zendy; Claudio Pizzocaro | Zendy; Giulia Lussignoli | Zendy; Cristina Geroldi | Zendy; Orazio Zanetti | Zendy; Maria Sofia Cotelli | Zendy; Marinella Turla | Zendy; Barbara Borroni | Zendy; Luca Rozzini | Zendy; Dario Mirabile | Zendy; Carlo Alberto Defanti | Zendy; Michele Gennuso | Zendy; A. Prelle | Zendy; Simona Gentile | Zendy; Alessandro Morandi | Zendy; Stefano Vollaro | Zendy; Giorgio Dalla Volta | Zendy; Angelo Bianchetti | Zendy; Marta Zaffira Conti | Zendy; Melania Cappuccio | Zendy; Pasqualina Carbone | Zendy; Daniele Bellandi | Zendy; L. Abruzzi | Zendy; L Bettoni | Zendy; Daniele Villani | Zendy; Maria Clara Raimondi | Zendy; Alessia Lanari | Zendy; Alfonso Ciccone | Zendy; Emanuela Facchi | Zendy; Ignazio Di Fazio | Zendy; Renzo Rozzini | Zendy; Stefano Boffelli | Zendy; Laura Manzoni | Zendy; Giovanni Pietro Salvi | Zendy; Sabina Cavaliere | Zendy; Gloria Belotti | Zendy; Stefano Avanzi | Zendy; Patrizio Pasqualetti | Zendy; Cristina Muscio | Zendy; Alessandro Padovani | Zendy; Giovanni B. Frisoni | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment

Author(s) -

Marina Boccardi,

Daniele Altomare,

Clarissa Ferrari,

Cristina Festari,

Ugo Paolo Guerra,

Barbara Paghera,

Claudio Pizzocaro,

Giulia Lussignoli,

Cristina Geroldi,

Orazio Zanetti,

Maria Sofia Cotelli,

Marinella Turla,

Barbara Borroni,

Luca Rozzini,

Dario Mirabile,

Carlo Alberto Defanti,

Michele Gennuso,

A. Prelle,

Simona Gentile,

Alessandro Morandi,

Stefano Vollaro,

Giorgio Dalla Volta,

Angelo Bianchetti,

Marta Zaffira Conti,

Melania Cappuccio,

Pasqualina Carbone,

Daniele Bellandi,

L. Abruzzi,

L Bettoni,

Daniele Villani,

Maria Clara Raimondi,

Alessia Lanari,

Alfonso Ciccone,

Emanuela Facchi,

Ignazio Di Fazio,

Renzo Rozzini,

Stefano Boffelli,

Laura Manzoni,

Giovanni Pietro Salvi,

Sabina Cavaliere,

Gloria Belotti,

Stefano Avanzi,

Patrizio Pasqualetti,

Cristina Muscio,

Alessandro Padovani,

Giovanni B. Frisoni

Publication year - 2016

Publication title -

jama neurology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.298

H-Index - 231

eISSN - 2168-6157

pISSN - 2168-6149

DOI - 10.1001/jamaneurol.2016.3751

Subject(s) - medicine , confidence interval , positron emission tomography , dementia , cognitive impairment , neuroimaging , alzheimer's disease , radiology , disease , psychiatry

Cerebral amyloidosis is a key abnormality in Alzheimer disease (AD) and can be detected in vivo with positron emission tomography (PET) ligands. Although amyloid PET has clearly demonstrated analytical validity, its clinical utility is debated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research